Bodycad USA Corp
$48.6K 51 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
FloSpine LLC
FloSpine LLC reported $48,666.84 across General Payments, Research, and Ownership to 25 physicians and teaching hospitals across 25 transactions.
- $48.7K Below-median payer
- All-tracks total
- 25 Below-median volume
- Transactions
- 25 Below-median reach
- Recipients
- −$114.2K
- General Payments vs PY2023
FloSpine LLC reported $48,666.84 across all CMS Open Payments tracks (General + Research + Ownership) to 25 physicians and teaching hospitals in Program Year 2024 - ranking #1355 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $48,666.84, averaging $1.9K per recipient.
FloSpine LLC's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
13/100
Total payments
F
10/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer flospine-llc FloSpine LLC
$48.7K · #1355/1,925 · 0.0% industry · PY2024
- TOT $48.7K
- RANK #1355
- SHARE 0.0%
- TXN 25
- RCP 25
- CAT 2
- GEN $48.7K
- ΔGEN −$114.2K
- TOP1 39.6%
- PY 2024
Volume peers
Nearest volume peer: Bodycad USA Corp ($48.6K)
FloSpine LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
FloSpine LLC's CMS-reported General Payments decreased by $114.2K (−70.1%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: FLOSPINE LLCPY2023: FLOSPINE LLCPY2024: FloSpine LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $162,882.34
- PY2024
- $48,666.84
What the Data Shows for FloSpine LLC
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For FloSpine LLC that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
Of the 2 general-payment categories charted below, "Royalty or License" is the largest at $25.3K across 9 transactions, 51.9% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Across 2 types of general payments, FloSpine LLC's largest category was "Royalty or License" at $25.3K - 51.9% of General Payments.
How FloSpine LLC divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Royalty or License | $25.3K | 9 | 51.9% |
| Consulting Fee | $23.4K | 16 | 48.1% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $44,274.45 (91.0%) of $48,666.84 in this company's General Payments records across 8 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for FloSpine LLC
The five named recipients with the highest reported General Payments from this company
- 1
John Afshar
$19,290.27 across 5 reported transactions
- 2
Cheng-Lun Soo
$8,834.22 across 2 reported transactions
- 3
John Cantando
$8,024.98 across 6 reported transactions
- 4
Yehuda Herschman
$5,950.00 across 4 reported transactions
- 5
Glen Manzano
$2,174.98 across 3 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
FloSpine LLC ranks #1355 of 1,925 by total payments (bottom 30% by spend) but is notably more concentrated than that alone would suggest -- #676 of 1,838 by HHI (top 37% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Kyowa Kirin Co., Ltd : $41.2K total payments, HHI 2391
- Miach Orthopaedics, Inc. : $1.0M total payments, HHI 2381
- SNAP Diagnostics LLC : $515.0K total payments, HHI 2374
- DeRoyal Industries, Inc. : $17.5K total payments, HHI 2374
- AGEPHA Pharma FZ LLC : $93.7K total payments, HHI 2373
- Access Vascular Inc : $27.0K total payments, HHI 2373
- FloSpine LLC (this company) : $48.7K total payments, HHI 2372
- RedDress USA, Inc. : $184.0K total payments, HHI 2360
- Cornerstone Specialty Network LLC : $120.5K total payments, HHI 2356
- Osteoremedies, LLC : $396.8K total payments, HHI 2355
- Avertix Medical, Inc : $164.0K total payments, HHI 2352
- Ricoh USA, Inc. : $336.00 total payments, HHI 2347
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as FloSpine LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about FloSpine LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with FloSpine LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
Vibrant Gastro, Inc.
$48.6K 96 recipients
Compare payment profiles
Alon Medical Technology
$48.8K 496 recipients
Compare payment profiles
Saxum Surgical, Inc.
$48.5K 331 recipients
Compare payment profiles
Protega Pharmaceutials Inc
$48.5K 1,404 recipients
Compare payment profiles
Naviswiss, Inc.
$48.9K 94 recipients
Compare payment profiles
Put this to use
FloSpine LLC ranks #1355 of 1,925 by all-tracks total payments, led by "Royalty or License".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Royalty or License" spend across every manufacturer, not just FloSpine LLC. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.